Drug intelligence / Profile preview

Miacell

Development stage: Preclinical
Lead developer: Cells for Cells
Modality: Stem Cell Therapies → Cell Therapies
Administration: Local Injection

Overview

Miacell is a cell therapy developed by the Chilean biotechnology company Cells for Cells (C4C) for the treatment of alopecia. As part of the company's dermatology (Dermo) portfolio, Miacell utilizes regenerative medicine approaches to promote hair regrowth and stimulate hair follicles. While specific molecular targets and clinical phase details are not extensively disclosed in public pipeline summaries, the therapy is built upon Cells for Cells' expertise in mesenchymal stem cell (MSC) research and cellular engineering, aiming to provide a biological solution for hair loss conditions.

Brand names: Miacell

Beyond the preview

Go deeper on Miacell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Miacell.

Explore the full profile